Copyright Reports & Markets. All rights reserved.

Global Cyclophosphamide for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cyclophosphamide for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Generic Drug
    • 1.3.3 Original Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cyclophosphamide for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Cyclophosphamide for Injection Market Size & Forecast
    • 1.5.1 Global Cyclophosphamide for Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cyclophosphamide for Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Cyclophosphamide for Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    • 2.1.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
    • 2.1.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
    • 2.1.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Cyclophosphamide for Injection Product and Services
    • 2.1.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
  • 2.2 Shanxi Powerdone Pharmaceutics Co., Ltd.
    • 2.2.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Details
    • 2.2.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Major Business
    • 2.2.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Cyclophosphamide for Injection Product and Services
    • 2.2.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments/Updates
  • 2.3 Hanhui Pharmaceuticals.
    • 2.3.1 Hanhui Pharmaceuticals. Details
    • 2.3.2 Hanhui Pharmaceuticals. Major Business
    • 2.3.3 Hanhui Pharmaceuticals. Cyclophosphamide for Injection Product and Services
    • 2.3.4 Hanhui Pharmaceuticals. Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hanhui Pharmaceuticals. Recent Developments/Updates
  • 2.4 Baxter Oncology GmbH
    • 2.4.1 Baxter Oncology GmbH Details
    • 2.4.2 Baxter Oncology GmbH Major Business
    • 2.4.3 Baxter Oncology GmbH Cyclophosphamide for Injection Product and Services
    • 2.4.4 Baxter Oncology GmbH Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Baxter Oncology GmbH Recent Developments/Updates
  • 2.5 Getwell Oncology
    • 2.5.1 Getwell Oncology Details
    • 2.5.2 Getwell Oncology Major Business
    • 2.5.3 Getwell Oncology Cyclophosphamide for Injection Product and Services
    • 2.5.4 Getwell Oncology Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Getwell Oncology Recent Developments/Updates
  • 2.6 Fresenius Kabi
    • 2.6.1 Fresenius Kabi Details
    • 2.6.2 Fresenius Kabi Major Business
    • 2.6.3 Fresenius Kabi Cyclophosphamide for Injection Product and Services
    • 2.6.4 Fresenius Kabi Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fresenius Kabi Recent Developments/Updates
  • 2.7 Amneal Pharmaceuticals, Inc.
    • 2.7.1 Amneal Pharmaceuticals, Inc. Details
    • 2.7.2 Amneal Pharmaceuticals, Inc. Major Business
    • 2.7.3 Amneal Pharmaceuticals, Inc. Cyclophosphamide for Injection Product and Services
    • 2.7.4 Amneal Pharmaceuticals, Inc. Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Amneal Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.8 Long Grove Pharmaceuticals, LLC
    • 2.8.1 Long Grove Pharmaceuticals, LLC Details
    • 2.8.2 Long Grove Pharmaceuticals, LLC Major Business
    • 2.8.3 Long Grove Pharmaceuticals, LLC Cyclophosphamide for Injection Product and Services
    • 2.8.4 Long Grove Pharmaceuticals, LLC Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Long Grove Pharmaceuticals, LLC Recent Developments/Updates
  • 2.9 AdvaCare Pharma
    • 2.9.1 AdvaCare Pharma Details
    • 2.9.2 AdvaCare Pharma Major Business
    • 2.9.3 AdvaCare Pharma Cyclophosphamide for Injection Product and Services
    • 2.9.4 AdvaCare Pharma Cyclophosphamide for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AdvaCare Pharma Recent Developments/Updates

3 Competitive Environment: Cyclophosphamide for Injection by Manufacturer

  • 3.1 Global Cyclophosphamide for Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cyclophosphamide for Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cyclophosphamide for Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cyclophosphamide for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cyclophosphamide for Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cyclophosphamide for Injection Manufacturer Market Share in 2025
  • 3.5 Cyclophosphamide for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Cyclophosphamide for Injection Market: Region Footprint
    • 3.5.2 Cyclophosphamide for Injection Market: Company Product Type Footprint
    • 3.5.3 Cyclophosphamide for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cyclophosphamide for Injection Market Size by Region
    • 4.1.1 Global Cyclophosphamide for Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cyclophosphamide for Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cyclophosphamide for Injection Average Price by Region (2021-2032)
  • 4.2 North America Cyclophosphamide for Injection Consumption Value (2021-2032)
  • 4.3 Europe Cyclophosphamide for Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cyclophosphamide for Injection Consumption Value (2021-2032)
  • 4.5 South America Cyclophosphamide for Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cyclophosphamide for Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Cyclophosphamide for Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Cyclophosphamide for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Cyclophosphamide for Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Cyclophosphamide for Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Cyclophosphamide for Injection Market Size by Country
    • 7.3.1 North America Cyclophosphamide for Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cyclophosphamide for Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cyclophosphamide for Injection Market Size by Country
    • 8.3.1 Europe Cyclophosphamide for Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cyclophosphamide for Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cyclophosphamide for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Cyclophosphamide for Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cyclophosphamide for Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Cyclophosphamide for Injection Market Size by Country
    • 10.3.1 South America Cyclophosphamide for Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cyclophosphamide for Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cyclophosphamide for Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cyclophosphamide for Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cyclophosphamide for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Cyclophosphamide for Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cyclophosphamide for Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cyclophosphamide for Injection Market Drivers
  • 12.2 Cyclophosphamide for Injection Market Restraints
  • 12.3 Cyclophosphamide for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cyclophosphamide for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cyclophosphamide for Injection
  • 13.3 Cyclophosphamide for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cyclophosphamide for Injection Typical Distributors
  • 14.3 Cyclophosphamide for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cyclophosphamide for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Cyclophosphamide for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cyclophosphamide for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cyclophosphamide for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cyclophosphamide for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cyclophosphamide for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cyclophosphamide for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cyclophosphamide for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanxi Powerdone Pharmaceutics Co., Ltd., Hanhui Pharmaceuticals., Baxter Oncology GmbH, Getwell Oncology, Fresenius Kabi, Amneal Pharmaceuticals, Inc., Long Grove Pharmaceuticals, LLC, AdvaCare Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cyclophosphamide for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Generic Drug
    Original Drug
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    Shanxi Powerdone Pharmaceutics Co., Ltd.
    Hanhui Pharmaceuticals.
    Baxter Oncology GmbH
    Getwell Oncology
    Fresenius Kabi
    Amneal Pharmaceuticals, Inc.
    Long Grove Pharmaceuticals, LLC
    AdvaCare Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cyclophosphamide for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cyclophosphamide for Injection, with price, sales quantity, revenue, and global market share of Cyclophosphamide for Injection from 2021 to 2026.
    Chapter 3, the Cyclophosphamide for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cyclophosphamide for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cyclophosphamide for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclophosphamide for Injection.
    Chapter 14 and 15, to describe Cyclophosphamide for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now